Webinar Summary
- An understanding of the genetic and non-genetic drivers of metastatic breast cancer
- Explore the limitations of current approaches to treatment of metastatic breast cancer
- Consider other strategies for targeting breast cancer
Invasive breast cancer is a major cause of disease and death among women. In particular, triple-negative breast cancer (TNBC), a subtype of breast cancer that is clinically aggressive with high rates of metastasis and recurrence, disproportionately affects women of African descent and carriers of germline BRCA and PALB2 mutations. Amongst younger patients with breast cancer, the TNBC subtype was associated with higher pathologic stage and worse long-term survival. Although we have made major strides due to earlier diagnoses and targeted therapy, the mainstay of treatment for metastatic TNBC is chemotherapy and discovery of effective metastatic breast cancer treatments are needed.
In this webinar, Dr. Rosner will present some of the key challenges we face in trying to eliminate metastatic breast cancer. She will present different strategies for trying to effectively target metastatic disease and, based upon her work, some novel approaches to addressing these problems.
Presenters
Marsha Rosner
Marsha Rich Rosner is the Charles B. Huggins Distinguished Service Professor at the University of Chicago. She was founder and first Chair of the graduate program in Cancer Biology and past Chair of the Ben May Department for Cancer Research. Among other honors, Dr. Rosner is a Fellow of the American Association for the Advancement of Science.
Content Partners
American Physiological Society
About APS
Mission: To advance scientific discovery, understand life, and improve health. Vision: A global multidisciplinary community of scientists solving the major problems affecting life and health. Founded in 1887, the American Physiological Society is a global leader in expanding knowledge related to biological function. We connect a multidisciplinary community of nearly 10,000 scientists and educators from around the world, driving collaboration and spotlighting scientific discoveries in physiology and related disciplines. Our members are advancing treatments and cures for everything from cancer and heart disease, to obesity and addiction. They are also deepening our insight into living organisms generally, helping us to better understand how things like climate change are affecting the world around us. The Society serves this dynamic community in many ways, including:- Publishing 16 globally recognized scholarly journals and a highly-regarded book monograph series;
- Sponsoring scientific meetings and symposia that explore the frontiers of bio-medical science;
- Advocating for science-smart public policy that benefits both our members and the public;
- Bestowing hundreds of awards, grants, and fellowships that recognize scientific excellence and promise;
- Championing physiology education and educators, to support bigger discoveries and better clinical outcomes;
- And providing career resources and other career services, ensuring that all our members have a pathway to success.
Society for Women’s Health Research
As a national thought leader dedicated to advancing women’s health and promoting research on sex differences to optimize women’s health, the Society for Women’s Health Research (SWHR) plays a critical role in identifying clinical and research gaps; raising awareness of diseases, conditions, and life stages that differently, disproportionately, or exclusively affect women; and promoting policies that could positively shape health outcomes for women. Over its more than 30-year history, SWHR has been advancing women’s health through its core functions of science, policy, and education.
Scientist.com
Scientist.com is the world’s largest and first platform built for the intricacies of scientific outsourcing.
We help pharmaceutical and biotechnology organizations discover, engage, manage, and scale relationships with the providers that support every stage of the pipeline—from discovery and preclinical research to clinical development, manufacturing, medical affairs, and commercialization. Through a centralized platform, organizations can access a global network of 6,000+ providers, streamline sourcing and procurement workflows, maintain compliance, manage supplier relationships, and leverage data-driven insights to make faster, more informed decisions.
Today, Scientist.com supports more than 130 life science organizations, including 24 of the world's top 30 pharmaceutical companies, helping teams reduce operational complexity, accelerate timelines, and bring innovations to patients faster. Our mission is to make it possible to cure all human disease by 2050.
